Literature DB >> 559256

Substituted benzamides as cerebral dopamine antagonists in rodents.

P N Elliott, P Jenner, G Huizing, C D Marsden, R Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 559256     DOI： 10.1016/0028-3908(77)90070-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN： 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  28 in total

1.  The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans.

Authors:  Madhav Thambisetty; Kathy A Gallardo; Jeih-San Liow; Lori L Beason-Held; John C Umhau; Abesh K Bhattacharjee; Margaret Der; Peter Herscovitch; Judith L Rapoport; Stanley I Rapoport
Journal:  J Cereb Blood Flow Metab       Date:  2011-12-14       Impact factor: 6.200

2.  Opposing actions of D-1 and D-2 dopamine receptor-mediated alterations of adenosine-3',5'-cyclic monophosphate (cyclic AMP) formation during the amphetamine-induced release of endogenous dopamine in vitro.

Authors:  A J Azzaro; J Liccione; J Lucci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

3.  Differential effects of benzamides and thioxanthenes on dopamine-elicited accumulation of cyclic AMP in isolated rabbit retina.

Authors:  P Magistretti; M Schorderet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-06       Impact factor: 3.000

4.  Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study.

Authors:  J A Stamford; Z L Kruk; J Millar
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

5.  Metoclopramide antagonism of 5-hydroxytryptophan-induced 'wet-dog' shake behaviour in the rat [proceedings].

Authors:  J R Fozard; M G Palfreyman
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

6.  Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.

Authors:  H B Niznik; D E Grigoriadis; I Pri-Bar; O Buchman; P Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

7.  Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.

Authors:  S Usuda; K Nishikori; O Noshiro; H Maeno
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Effects of metoclopramide and isoprenaline in the rat vas deferens; interactions with alpha-adrenoceptors.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

9.  Effects of tiapride on homovanillic acid levels in human cerebrospinal fluid drawn at pneumoencephalography.

Authors:  A Spissu; S Congia; M P Piccardi; F Fadda; A Mangoni; G L Gessa
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

10.  Antidepressant versus neuroleptic activities of sulpiride isomers on four animal models of depression.

Authors:  A Vaccheri; R Dall'Olio; R Gaggi; O Gandolfi; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.